Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.. Jaïs, X; Brenot, P; Bouvaist, H; Jevnikar, M; Canuet, M; Chabanne, C; Chaouat, A; Cottin, V; De Groote, P; Favrolt, N; Horeau-Langlard, D; Magro, P; Savale, L; Prévot, G; Renard, S; Sitbon, O; Parent, F; Trésorier, R; Tromeur, C; Piedvache, C; Grimaldi, L; Fadel, E; Montani, D; Humbert, M; Simonneau, G. Lancet Respir Med. 2022; 10: p.961-971. doi:10.1016/S2213-2600(22)00214-4
Article